Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rotoli

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
American Journal of Hematology|June 1, 1997
High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in ItalyG De Rosa, M L Gobbo, A De Renzo, et al.
Leukemia|July 14, 2006
TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemiaR Rosati, R La Starza, L Luciano, et al.
Leukemia|September 26, 1997
JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesisR Di Noto, L Luciano, C Lo Pardo, et al.
Bone Marrow Transplantation|June 18, 1999
Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplantC Selleri, J P Maciejewski, G De Rosa, et al.
Leukemia|October 6, 2001
Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphomaR Di Noto, F Pane, A Camera, et al.
Leukemia|March 4, 2005
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemiaF Pane, G Cimino, B Izzo, et al.
Blood|September 25, 1998
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow TransplantationM T Van Lint, C Uderzo, A Locasciulli, et al.
Leukemia|January 30, 2004
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trialsL Pagano, A Pulsoni, M E Tosti, et al.
Bone Marrow Transplantation|June 1, 1996
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative GroupsS Keating, S Suciu, T de Witte, et al.
Recenti Progressi in Medicina|April 29, 1998
[High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study]C Catassi, E Fabiani, G V Coppa, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
American Journal of Hematology|June 1, 1997
High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in ItalyG De Rosa, M L Gobbo, A De Renzo, et al.
Leukemia|July 14, 2006
TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemiaR Rosati, R La Starza, L Luciano, et al.
Leukemia|September 26, 1997
JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesisR Di Noto, L Luciano, C Lo Pardo, et al.
Bone Marrow Transplantation|June 18, 1999
Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplantC Selleri, J P Maciejewski, G De Rosa, et al.
Leukemia|October 6, 2001
Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphomaR Di Noto, F Pane, A Camera, et al.
Leukemia|March 4, 2005
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemiaF Pane, G Cimino, B Izzo, et al.
Blood|September 25, 1998
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow TransplantationM T Van Lint, C Uderzo, A Locasciulli, et al.
Leukemia|January 30, 2004
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trialsL Pagano, A Pulsoni, M E Tosti, et al.
Bone Marrow Transplantation|June 1, 1996
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative GroupsS Keating, S Suciu, T de Witte, et al.
Recenti Progressi in Medicina|April 29, 1998
[High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study]C Catassi, E Fabiani, G V Coppa, et al.
Pageof 15